Glaxosmithkline Share News (GSK)
GSK Share
GSK Share
GSK Share
GSK Share
GSK
GSK Share
GSK Level 2
GSK Live
GSK Broker
GSK Directors
GSK Financial
GSK
GSK Short
GSK
Last checked at -
By Nancy LapidMay 28 (Reuters) - The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.India variant shows resistance ...
Read more
(Sharecast News) - Activist investor Elliott Management will not call for GlaxoSmithKline to sell its vaccines and pharmaceuticals business after taking a big stake in the FTSE 100 drugs company, The Times reported.
Read more(Sharecast News) - GlaxoSmithKline announced on Wednesday that 'sotrovimab' has received emergency use approval in the United States for the treatment of Covid-19, while it also started a global phase 3 study of its Covid-19 vaccine candidate with Sanofi.
Read more(Adds details, quote)By Dominique VidalonPARIS, May 27 (Reuters) - France's Sanofi and Britain's GlaxoSmithKline launched a late-stage human trial for a recombinant COVID-19 vaccine candidate on Thursday which they hope to get approved by the end ...
Read more
TOP NEWS: GSK and Sanofi launch phase three study for Covid vaccine
Read morePARIS, May 27 (Reuters) - Sanofi and GlaxoSmithKline said on Thursday they were launching Phase III trial, the late-stage before submitting approval, for their experimental COVID-19 vaccine.Pending positive phase III outcome, the vaccine could be ...
Read moreUS regulator authorises GSK and Vir's sotrovimab for Covid treatment
Read moreIN BRIEF: Crossword Cybersecurity bolsters board with two appointments
Read more(Sharecast News) - Travis Perkins: Deutsche Bank resumes coverage with a recommendation to hold and a target price of 1,707p.
Read more(Sharecast News) - The European Medicines Agency's Committee for Human Medicinal Products issued a 'positive scientific opinion' for the Covid-19 treatment developed by GlaxoSmithKline and Vir Biotechnology, sotrovimab.
Read moreIN BRIEF: GlaxoSmithKline's sotrovimab gets EMA positive opinion
Read more* GSK sells 32% stake in product portfolio company* Innoviva was separated from Theravance in 2014* GSK says royalty agreements with Innoviva unchanged (Adds details on Innoviva)May 20 (Reuters) - GlaxoSmithKline has sold its entire stake in Innovi...
Read moreGlaxoSmithKline sells entire Innoviva stake for USD392 million
Read more(Adds background, comment from Sandoz CEO)ZURICH, May 18 (Reuters) - Swiss drugmaker Novartis's Sandoz generics unit will close one Spanish site, expand another and proceed with a new Austrian facility, it said on Tuesday, as it revamps its Europe...
Read moreTOP NEWS: GlaxoSmithKline and Medicago hail Covid-19 vaccine results
Read more
Last checked at